Krystal Biotech buy Citigroup Inc.
Start price
12.10.23
/
50%
€106.00
Target price
12.10.24
-
Performance (%)
55.14%
End price
13.10.24
€164.45
Summary
This prediction ended on 13.10.24 with a price of €164.45. The BUY prediction by Citigroup_Inc_ for Krystal Biotech saw massive gains of 55.14%. Citigroup_Inc_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 18.919% | 18.919% | 81.018% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Krystal Biotech
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
